Omnia Ventures Group leverages decades of institutional investing experience to identify and support the scientific breakthroughs that will define the next era of healthcare. We combine deep domain expertise with advanced analytics to inform investment decisions across therapeutics, diagnostics, longevity, and enabling technologies. Our team is committed to partnering with innovators whose work has the potential to transform patient outcomes and reshape the global biotech landscape.